Teprotumumab for Active Thyroid Eye Disease

N Engl J Med. 2020 May 14;382(20):1959. doi: 10.1056/NEJMc2002754.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Graves Ophthalmopathy*
  • Humans

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • teprotumumab